Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H14F4N2O4S |
Molecular Weight | 430.373 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC=C(C#N)C(=C2)C(F)(F)F
InChI
InChIKey=LKJPYSCBVHEWIU-UHFFFAOYSA-N
InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)
Molecular Formula | C18H14F4N2O4S |
Molecular Weight | 430.373 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:35:20 UTC 2023
by
admin
on
Fri Dec 15 18:35:20 UTC 2023
|
Record UNII |
A0Z3NAU9DP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QL02BB03
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
||
|
NDF-RT |
N0000000243
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
||
|
WHO-ATC |
L02AE51
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
||
|
NCI_THESAURUS |
C146993
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
||
|
WHO-ATC |
L02BB03
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
||
|
NDF-RT |
N0000175560
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
||
|
LIVERTOX |
NBK547970
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
A0Z3NAU9DP
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
BICALUTAMIDE
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
367
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
SUB05817MIG
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
2375
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
DTXSID2022678
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
2863
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
C053541
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
7021
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
C1599
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
GG-51
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
83008
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | RxNorm | ||
|
1071202
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
90357-06-5
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
CHEMBL409
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
759816
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
7655
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
m2474
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000085878
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
A0Z3NAU9DP
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
DB01128
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY | |||
|
3090
Created by
admin on Fri Dec 15 18:35:20 UTC 2023 , Edited by admin on Fri Dec 15 18:35:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE ISOMER -> PARENT | |||
|
INACTIVE ISOMER -> PARENT |
Bicalutamide is a racemate and its antiandrogenic activity resides almost exclusively in the (R)-enantiomer, with little, if any, activity in the (S)-enantiomer.
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
TARGET -> INHIBITOR | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> AGONIST |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||